2019 Chronic Lymphocytic Leukaemia (CLL) TP53 (pilot)

Scheme description
2019 CLL TP53 variant detection pilot - DNA and lyophilised cells are distributed for analysis. Analysis will include any technique for the detection of TP53 variants
Disorders/Gene target(s)
Chronic Lymphocytic Leukaemia (CLL)
TP53
Clinical cases
Four
Testing/analysis
Any methodology
Sample type
DNA and lyophilised cells
Techniques
Any
Assessment
Technical, Genotyping and Interpetation
Eligibility
Any ERIC certified laboratory
Languages
English
ISO1743 Accredited EQA
No
EQA timeline
Sample dispatch
Testing period
Assessment results
Final Summary report
Other information
Fee
£0.00
GenQA code
2019CLLTP53
« Return to EQA scheme list
Go to top